康艾注射液在乳腺癌化疗或术后恢复中的作用

Effect of Kangai Injection Used with Breast Cancer Chemotherapy and Postoperation

目的观察康艾注射液在乳腺癌化疗或术后恢复中的辅助治疗作用。方法采用病例对照研究的方法比较康艾治疗组与对照组的疗效、毒副反应和术后恢复情况,χ2检验的方法分析统计数据。结果康艾治疗组较对照组的新辅助化疗疗效更好(康艾组化疗有效率75.64%,对照组68.75%)但差异无统计学意义;康艾治疗组较对照组化疗的毒副反应更轻,术后恢复更好,术后按期化疗的比例更高,差异均有统计学意义(P<0.05)。结论康艾注射液可以减轻乳腺癌化疗的毒副反应,促进乳腺癌术后恢复。

Objective Adjuvant therapy of Kangai injection was observed in breast cancer chemotherapy or postoperative recovery. Methods The difference of efficacy, toxicity, and postoperative recovery between Kangai treatment group and control group was compared by case-control study methods. All the data was analyzed by χ^2 test. Results The neo-adjuvant chemotherapy response rate of Kangai treatment group was higher than the control group （Kangai treatment group,75.64; the control group,68. 75）, but there was no significant difference. Compared with the control group, Kangai treatment group was lower chemotherapy toxicity, better postoperative recovery, higher proportion of regular early postoperative chemotherapy, all the differences were statistically significant （P〈0. 05 ）. Conclusion Kangai injection of breast cancer can reduce the toxicity of chemotherapy, promote postoperative recovery of breast cancer and help breast cancer patient on a regular early chemotherapy.